TG Therapeutics, Inc. (LON:0VGI)
London
· Delayed Price · Currency is GBP · Price in USD 37.50
-1.05 (-2.72%)
At close: Mar 14, 2025
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of 5.19 billion as of May 5, 2025. Its market cap has increased by 222.80% in one year.
Market Cap
5.19B
Enterprise Value
5.15B
Revenue
262.80M
Ranking
n/a
PE Ratio
277.77
Stock Price
37.50
Market Cap Chart
Since January 10, 2012, TG Therapeutics's market cap has increased from 6.62M to 5.19B, an increase of 78,304.10%. That is a compound annual growth rate of 64.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 164.49B |
| GSK plc | 59.24B |
| Haleon | 35.05B |
| Smith & Nephew | 9.43B |
| ConvaTec Group | 5.35B |
| Hikma Pharmaceuticals | 4.41B |
| HUTCHMED (China) | 1.94B |
| Genus | 1.31B |